Cancer Stem Cells

Which Part of Stem Cells Should Be Treated?

Dr Wainberg and Dr Gerson discuss the ongoing debate about whether clinicians should treat the surface or the internal structure of cancer stem cells.

Which Part of Stem Cells Should Be Treated?

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Dr Wainberg and Dr Gerson talk about the results of using investigational agent BBI608 combined with another drug that is used as a standard of care.

Discussing the Results of BBI608 Combined with Another Therapeutic Agent

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Do Therapeutic Agents Affect Healthy Stem Cells?

Dr Wainberg and Dr Gerson ponder and provide opinions on whether these investigational therapies also target healthy cells.

Do Therapeutic Agents Affect Healthy Stem Cells?

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.

Targeting Resistant Cells

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Which Stem Cell Properties Drive Which Cancers?

Dr Wainberg and Dr Gerson review the characteristics of these stem cells, what some of the medicines are doing right now, and some of the expectations in future clinical trials.

Which Stem Cell Properties Drive Which Cancers?

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Relapsing Cancer

Dr Wainberg and Dr Gerson share their postulation that stem cells may play a role in cancer recurrences.

Relapsing Cancer

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Defining Cancer Stem Cells

Dr Gerson provides an overview of cancer stem cells.

Defining Cancer Stem Cells

Video Categories: Cancer Stem Cells and PMO Interview with the Innovator Series: Volume 11

Sign me up!